ACA may be to blame for life sciences company's struggles; Universal American to sell off traditional insurance business;

News From Around the Web

> A paper from the Brookings Institute's Hamilton Project outlines six economic facts that "highlight continuing challenges and complexities in healthcare and health insurance markets on which the policy debate should focus." Paper (.pdf)

> The fate of Wisconsin-based Exact Sciences, which manufactures a new colon-cancer screening test, serves as a cautionary tale about how damaging the Affordable Care Act can be to small life-sciences companies, writes Forbes contributor Arlene Weinstraub. Article

> Universal American Corp. will sell its traditional insurance business--which includes Medicare supplement, long-term care, disability, life and other ancillary insurance products--to Nassau Reinsurance Group Holdings L.P., the company announced Thursday. Announcement

Health Finance News

> Connecticut's slashing of Medicaid dollars to hospitals in an attempt to balance its budget has claimed at least one hospital deal as collateral damage, according to the Hartford Courant. Article

Health IT News

> While engagement of patients in their own care is vital to improving the health industry, achieving success is a difficult task, panelists said Wednesday at the HIMSS Policy Summit in the District of Columbia. Article

And finally… If you don't remember it, it doesn't count. Article

Suggested Articles

With large numbers of Americans skeptical of a COVID-19 vaccine, CVS views its pharmacists as playing a key role in assuaging fears, said its CEO.

The COVID-19 pandemic is driving enormous demand for virtual mental health care services. Here is how much utilization has increased during COVID-19.

Blue Cross NC is launching two new digital programs targeting smoking cessation and Type 2 diabetes management next month at no cost to members.